Mobiflex (Indometacin)

Indometacin is used to manage pain and inflammation in several musculoskeletal and inflammatory conditions.

• Arthritis: alleviates joint pain and swelling in rheumatoid and osteoarthritis.
• Musculoskeletal pain: reduces discomfort from sprains, strains and overuse injuries.
• Acute inflammation: diminishes localized inflammatory responses after trauma or surgery.
• Tendinitis: eases pain and improves function in inflamed tendons.

• Indometacin exerts its effect by reversibly inhibiting cyclooxygenase (COX‑1 and COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The resulting decrease in prostaglandin synthesis leads to reduced inflammation, pain perception, and fever at the site of application.

Topical indometacin may cause local and systemic adverse reactions.

Common Side Effects

• Skin irritation: redness, itching or burning at the application site.
• Dryness: localized skin dryness or flaking.
• Pruritus: mild itching sensation.
• Erythema: mild redness of the skin.
• Contact dermatitis: allergic skin reaction in sensitive individuals.

Serious or Rare Side Effects

• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Systemic NSAID effects: gastrointestinal ulceration or bleeding.
• Renal impairment: reduced kidney function with extensive use.
• Hepatotoxicity: liver enzyme elevations.
• Hypersensitivity: anaphylaxis or severe allergic response.

When using Mobiflex, consider the following safety measures.

• Avoid broken skin: do not apply to open wounds or damaged skin.
• Limit exposure: use only the prescribed area and duration.
• Monitor for reactions: discontinue if severe skin irritation or systemic symptoms develop.
• Caution with other NSAIDs: avoid concurrent systemic NSAID therapy to reduce risk of adverse effects.
• Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited.
• Store at room temperature: keep below 25°C, in the original packaging, protected from moisture and direct sunlight.

Indometacin may interact with several drug classes, affecting safety or efficacy.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.
• Corticosteroids: amplified risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in renal function.
• Diuretics: may enhance renal adverse effects.
• Lithium: increased lithium levels leading to toxicity.
• Methotrexate: reduced clearance, raising toxicity risk.